Search

7 results for “tender offer

Centaurus Fund Challenges $1.2 Billion Mandatory Tender Offer for Oncoclínicas in Arbitration
PROInvestingSep 11

Centaurus Fund Challenges $1.2 Billion Mandatory Tender Offer for Oncoclínicas in Arbitration

A fund linked to Centaurus Capital is seeking to annul a CVM decision mandating a R$6 billion tender offer for Oncoclínicas shares, pitting minority rights against a major investor.

Ecopetrol Tender Offer for Brava Energia (BRAV3) Closes Today on B3 at R$23.00
MarketsAug 05

Ecopetrol Tender Offer for Brava Energia (BRAV3) Closes Today on B3 at R$23.00

Colombia’s Ecopetrol closes tender offer for Brazil’s Brava Energia (BRAV3) on the B3, aiming for a controlling stake.

Ecopetrol’s R$23 OPA for Brava Energia (BRAV3) Sets Price Floor in Partial Tender Auction on B3
PROSmall CapsAug 05

Ecopetrol’s R$23 OPA for Brava Energia (BRAV3) Sets Price Floor in Partial Tender Auction on B3

Colombian energy giant Ecopetrol holds a partial tender offer auction today for 25% of Brava Energia (BRAV3) to secure a controlling stake.

Natura Controllers Seek OPA Waiver as Advent International Secures Board Seats
PROMarketsAug 03

Natura Controllers Seek OPA Waiver as Advent International Secures Board Seats

Cosmetics giant Natura &Co's controllers push to waive a mandatory tender offer as private equity firm Advent finalizes its strategic 8%-10% stake.

Santander Brazil Units Surge 15.2% on Parent's €1.9 Billion Share-Swap Tender Offer
PROInvestingAug 03

Santander Brazil Units Surge 15.2% on Parent's €1.9 Billion Share-Swap Tender Offer

Banco Santander S.A.'s voluntary offer for the remaining 10% of its Brazilian subsidiary, offering a 15% premium, sparked a rally in SANB11.

Santander Spain Offers 15% Premium in €1.9B Exchange Offer for Santander Brasil (SANB11) Minority Shares
PROMarketsJul 31

Santander Spain Offers 15% Premium in €1.9B Exchange Offer for Santander Brasil (SANB11) Minority Shares

Santander Spain launched a voluntary tender offer for 10% of SANB11 shares, offering a 15% premium to swap them for BDRs/ADSs of the parent company.

CVM Rules in Favor of Goldman Sachs and Centaurus on Oncoclínicas
MarketsJul 01

CVM Rules in Favor of Goldman Sachs and Centaurus on Oncoclínicas

Brazil's CVM ruled that Centaurus Capital's share acquisition did not trigger a mandatory tender offer (OPA) for Oncoclínicas, relieving capital risk.